Baidu
map

预告:第二届中国实效研究和循证医学高峰会议 (CORE SUMMIT)

2012-03-28 MedSci MedSci原创

由中国医师协会和美国华斯泰生命策略研究所(VitalStrategic Research Institute)联合举办的【第二届中国实效研究和循证医学高峰会议】(简称CORE Summit) 将于2012年3月30-31日于上海国际会议中心召开。CORE Summit是中国唯一的致力于实效研究 (outcomes research)、对比性效益研究 (comparative effectivene

由中国医师协会和美国华斯泰生命策略研究所(VitalStrategic Research Institute)联合举办的【第二届中国实效研究和循证医学高峰会议】(简称CORE Summit) 将于2012年3月30-31日于上海国际会议中心召开。CORE Summit是中国唯一的致力于实效研究 (outcomes research)、对比性效益研究 (comparative effectiveness research), 医疗管理技术评估(Health Technology Assessment),和电子医学 (eHealth)的国际会议

大会将采用专题讲座同主题发言相结合的形式进行。一共有以下六个专题讲座:
主题1–实效研究的过去,现在和将来
主题2–循证医学对企业策略,政府政策和临床实践的影响
主题3–以价值为导向的医疗和成本效益研究
主题4–综合疾病管理和个性化医疗
主题5–电子医学的现在和将来
主题6–统计模型和疾病预测

在职临床医生可以申请由中国医师协会管理并且授予的“继续医学教育”学分。

MedSci作为专业的科研和临床学术服务平台,在临床科研教育培训中,一直积极地传播与分享“循证医学分析的研究过程、循证医学选题及分析方法、循证医学与临床争议问题解析”等主题内容,受到广大参与者的欢迎与积极回应。
Medsci受邀将参加本次会议,欢迎广大科研工作者届时与我们面对面交流!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1795195, encodeId=8b5d1e9519534, content=<a href='/topic/show?id=aeac1689e5b' target=_blank style='color:#2F92EE;'>#SUMMIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16897, encryptionId=aeac1689e5b, topicName=SUMMIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 11 05:07:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900785, encodeId=27861900e854b, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11959, encryptionId=5f9b119599d, topicName=MIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Jul 23 14:07:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022438, encodeId=613020224388a, content=<a href='/topic/show?id=53564603527' target=_blank style='color:#2F92EE;'>#实效研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46035, encryptionId=53564603527, topicName=实效研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Tue Oct 30 04:07:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379428, encodeId=a1ff13e9428ac, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449637, encodeId=76ba144963ecc, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561977, encodeId=271115619e7e4, content=<a href='/topic/show?id=309f509e9a' target=_blank style='color:#2F92EE;'>#CORE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5097, encryptionId=309f509e9a, topicName=CORE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=)]
    2012-07-11 huirong
  2. [GetPortalCommentsPageByObjectIdResponse(id=1795195, encodeId=8b5d1e9519534, content=<a href='/topic/show?id=aeac1689e5b' target=_blank style='color:#2F92EE;'>#SUMMIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16897, encryptionId=aeac1689e5b, topicName=SUMMIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 11 05:07:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900785, encodeId=27861900e854b, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11959, encryptionId=5f9b119599d, topicName=MIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Jul 23 14:07:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022438, encodeId=613020224388a, content=<a href='/topic/show?id=53564603527' target=_blank style='color:#2F92EE;'>#实效研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46035, encryptionId=53564603527, topicName=实效研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Tue Oct 30 04:07:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379428, encodeId=a1ff13e9428ac, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449637, encodeId=76ba144963ecc, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561977, encodeId=271115619e7e4, content=<a href='/topic/show?id=309f509e9a' target=_blank style='color:#2F92EE;'>#CORE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5097, encryptionId=309f509e9a, topicName=CORE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=)]
    2012-07-23 gracezdd
  3. [GetPortalCommentsPageByObjectIdResponse(id=1795195, encodeId=8b5d1e9519534, content=<a href='/topic/show?id=aeac1689e5b' target=_blank style='color:#2F92EE;'>#SUMMIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16897, encryptionId=aeac1689e5b, topicName=SUMMIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 11 05:07:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900785, encodeId=27861900e854b, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11959, encryptionId=5f9b119599d, topicName=MIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Jul 23 14:07:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022438, encodeId=613020224388a, content=<a href='/topic/show?id=53564603527' target=_blank style='color:#2F92EE;'>#实效研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46035, encryptionId=53564603527, topicName=实效研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Tue Oct 30 04:07:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379428, encodeId=a1ff13e9428ac, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449637, encodeId=76ba144963ecc, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561977, encodeId=271115619e7e4, content=<a href='/topic/show?id=309f509e9a' target=_blank style='color:#2F92EE;'>#CORE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5097, encryptionId=309f509e9a, topicName=CORE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1795195, encodeId=8b5d1e9519534, content=<a href='/topic/show?id=aeac1689e5b' target=_blank style='color:#2F92EE;'>#SUMMIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16897, encryptionId=aeac1689e5b, topicName=SUMMIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 11 05:07:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900785, encodeId=27861900e854b, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11959, encryptionId=5f9b119599d, topicName=MIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Jul 23 14:07:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022438, encodeId=613020224388a, content=<a href='/topic/show?id=53564603527' target=_blank style='color:#2F92EE;'>#实效研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46035, encryptionId=53564603527, topicName=实效研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Tue Oct 30 04:07:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379428, encodeId=a1ff13e9428ac, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449637, encodeId=76ba144963ecc, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561977, encodeId=271115619e7e4, content=<a href='/topic/show?id=309f509e9a' target=_blank style='color:#2F92EE;'>#CORE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5097, encryptionId=309f509e9a, topicName=CORE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1795195, encodeId=8b5d1e9519534, content=<a href='/topic/show?id=aeac1689e5b' target=_blank style='color:#2F92EE;'>#SUMMIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16897, encryptionId=aeac1689e5b, topicName=SUMMIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 11 05:07:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900785, encodeId=27861900e854b, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11959, encryptionId=5f9b119599d, topicName=MIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Jul 23 14:07:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022438, encodeId=613020224388a, content=<a href='/topic/show?id=53564603527' target=_blank style='color:#2F92EE;'>#实效研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46035, encryptionId=53564603527, topicName=实效研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Tue Oct 30 04:07:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379428, encodeId=a1ff13e9428ac, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449637, encodeId=76ba144963ecc, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561977, encodeId=271115619e7e4, content=<a href='/topic/show?id=309f509e9a' target=_blank style='color:#2F92EE;'>#CORE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5097, encryptionId=309f509e9a, topicName=CORE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=)]
    2012-03-30 xjy04
  6. [GetPortalCommentsPageByObjectIdResponse(id=1795195, encodeId=8b5d1e9519534, content=<a href='/topic/show?id=aeac1689e5b' target=_blank style='color:#2F92EE;'>#SUMMIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16897, encryptionId=aeac1689e5b, topicName=SUMMIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Wed Jul 11 05:07:00 CST 2012, time=2012-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900785, encodeId=27861900e854b, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11959, encryptionId=5f9b119599d, topicName=MIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Mon Jul 23 14:07:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022438, encodeId=613020224388a, content=<a href='/topic/show?id=53564603527' target=_blank style='color:#2F92EE;'>#实效研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46035, encryptionId=53564603527, topicName=实效研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Tue Oct 30 04:07:00 CST 2012, time=2012-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379428, encodeId=a1ff13e9428ac, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449637, encodeId=76ba144963ecc, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561977, encodeId=271115619e7e4, content=<a href='/topic/show?id=309f509e9a' target=_blank style='color:#2F92EE;'>#CORE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5097, encryptionId=309f509e9a, topicName=CORE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Fri Mar 30 08:07:00 CST 2012, time=2012-03-30, status=1, ipAttribution=)]
    2012-03-30 docwu2019
Baidu
map
Baidu
map
Baidu
map